Lycopene can reduce prostate-specific antigen velocity in a phase ii clinical study in Chinese population

Chinese Medical Journal

Volumn 127, Issue 11, 2014, Pages 2143-2146

  Zhang, Xin ^a   Yang, Yong ^a   Wang, Qi ^b  

^a PEKING UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lycopene; Prostate cancer; Prostate specific antigen

Indexed keywords

CAROTENOID; LYCOPENE; PROSTATE SPECIFIC ANTIGEN;

AGED; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; METABOLISM; PHASE 2 CLINICAL TRIAL; PROSTATIC NEOPLASMS;

AGED; CAROTENOIDS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84901660640     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20132829     Document Type: Article

References (21)

1. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Herbal antioxidant in clinical practice: a review. Asian Pac J Trop Biomed 2014; 4: 78-84.
2. Belter A, Giel-Pietraszuk M, Oziewicz S, Chomczyński P, Barciszewski J. Lycopene--occurrence, properties and applications. Postepy Biochem 2011; 57: 372-380.
3. Holzapfel NP, Holzapfel BM, Champ S, Feldthusen J, Clements J, Hutmacher DW. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci 2013; 14: 14620-14646.
4. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87: 1767-1776.
5. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993; 90: 7915-7922.
6. Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas 2012; 72: 269-276.
7. Barber NJ, Barber J. Lycopene and prostate cancer. Prostate Cancer Prostatic Dis 2002; 5: 6-12.
8. Wang A, Zhang L. Effect of lycopene on proliferation and cell cycle of hormone refractory prostate cancer PC-3 cell line (in Chinese). J Hyg Res 2007; 36: 575-578.
9. Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 2004; 7: 284-289.
10. Chen J, Song Y, Zhang L. Effect of lycopene supplementation on oxidative stress: an exploratory systematic review and meta-analysis of randomized controlled trials. J Med Food 2013; 16: 361-374.
11. Barber NJ, Zhang X, Zhu G, Pramanik R, Barber JA, Martin FL, et al. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specifc antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis 2006; 9: 407-413.
12. Zhang X, Wang Q, Neil B, Chen X. Effect of lycopene on androgen receptor and prostate-specific antigen velocity. Chin Med J 2010; 123: 2231-2236.
13. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 43-68.
14. Gu F. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Chin Med J 2000; 113: 299-302.
15. Baena Ruiz R, Salinas Hernández P. Diet and cancer: Risk factors and epidemiological evidence. Maturitas 2014; 77: 202-208.
16. Parsons JK, Marshall JR, Nelson H. Does altering diet affect progression of prostate cancer? The MEAL study. Bull Am Coll Surg 2013; 98: 57-59.
17. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001; 131: 3303-3306.
18. Kim L, Rao AV, Rao LG. Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 2002; 5: 181-187.
19. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001; 10: 861-868.
20. Ansari MS, Sgupta NP. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 2005; 95: 453.
21. Richards LR, Benghuzzi H, Tucci M, Hughes J. The synergistic effect of conventional and sustained delivery of antioxidants on LnCaP prostate cancer cell lines. Biomed Sci Instrum 2003; 39: 402-407.